CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 3,739,948	$ 4,703,160	$ 12,184,276	$ 13,684,204
General and administrative	1,748,935	1,967,075	6,592,128	6,547,866
Total operating expenses	5,488,883	6,670,235	18,776,404	20,232,070
Operating loss	(5,488,883)	(6,670,235)	(18,776,404)	(20,232,070)
Interest expense, net	(172,050)	(190,705)	(520,439)	(571,102)
Other expense	(3,771)	4,382	(13,312)	(7,801)
Net loss	(5,664,704)	(6,856,558)	(19,310,155)	(20,810,973)
Modification of warrants	0	(659,456)	0	(659,456)
Net loss available to common shareholders	$ (5,664,704)	$ (7,516,014)	$ (19,310,155)	$ (21,470,429)
Net loss per common share - basic and diluted	$ (1.36)	$ (4.18)	$ (6.34)	$ (12.51)
Weighted average common shares outstanding - basic and diluted	4,150,702	1,799,813	3,046,400	1,715,982